Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (1159)

« Back to Publications

Assessing the association between COVID-19 vaccination and thrombotic thrombocytopenia syndrome (ATTEST Study): Analyses of English data, 2020-2022

Ordóñez-Mena JM. et al, (2026), International Journal of Infectious Diseases, 164

Differentiating the COVID-19 Infection and Vaccine Experiences of Patients With Systemic, Single Organ, and Overlap Immune-Mediated Inflammatory Disease: Protocol for a Secondary Analysis for Enhancing COVID-19 Vaccine Pharmacovigilance.

Leston M. et al, (2026), JMIR Res Protoc, 15

Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trial.

Carr M. et al, (2026), Trials

SAFER: A Programme of Research to Determine if Intermittent Single-Lead ECG Screening for Atrial Fibrillation Reduces the Risk of Stroke.

Mant J. et al, (2026), Thromb Haemost

Incidental ambulatory ECG findings during atrial fibrillation screening in community-based populations: A systematic review and meta-analysis.

Brik T. et al, (2026), Heart Rhythm

Risk prediction models for detecting a new diagnosis of heart failure within 5 years in the community: a systematic review

Thaitirarot C. et al, (2026), BMJ Open, 16

Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients: Evidence from the UK PANORAMIC Trial

PNG ME. et al, (2026), JAMA Network Open

Recent-onset atrial fibrillation: challenges and opportunities

Svennberg E. et al, (2026), European Heart Journal, 47, 170 - 187

Erratum: Correction: The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study (PLoS medicine (2023) 20 4 DOI: 10.1371/journal.pmed.1004223.)

Sheppard JP. et al, (2026), Plos Medicine, 23

Stroke Action Plan for Europe 2018-2030 (SAP-E): mid-term review and update

Christensen H. et al, (2026), European Stroke Journal, 11

Natriuretic peptides testing and survival prediction models for chronic heart failure: a systematic review of added prognostic value.

Smith CA. et al, (2025), Diagn Progn Res, 9

Screening for atrial fibrillation with or without general practice involvement: a controlled study

Modi RN. et al, (2025), BMC Primary Care, 26

Economic burden of heart failure in Europe: A systematic review of costs and cost-effectiveness

Darbà J. et al, (2025), Esc Heart Failure, 12, 4055 - 4068

Agreement and utility of coded primary and secondary care data for long-term follow-up of clinical trial outcomes

Wang A. et al, (2025), BMC Medical Research Methodology, 25

Temporality might matter in people with atrial fibrillation and heart failure

Jones NR. et al, (2025), Lancet Healthy Longevity, 6

Load More

1
2
3
4
5
6
7
...
»